Site Editor

Soo Park, MD

Advertisement

Advertisement

News

Intradermal Injection of Axitinib Being Tested in Nonmelanoma Skin Cancers

Medical Literature

Researchers Shed Light on Role of CD8-Positive T Cells in Progression of Melanoma

Medical Literature

Nonmelanoma Skin Cancer: Improving Adherence to NCCN Guidelines for Preferred Treatment

Medical Literature

Is Access to Tanning Bed Facilities Linked to Regional Melanoma Rates?

News

Does Skin Screening Alter the Incidence of Skin Cancer? Australian Researchers Weigh In

News

Pediatric Cutaneous Melanoma: Recommendations for Diagnosis and Treatment

Medical Literature

Germline Genetic Variation and Development of In Situ or Invasive Melanoma

Christian U. Blank, MD, PhD, on Clinical Implications of New Findings on Neoadjuvant Nivolumab Plus Ipilimumab in Melanoma

Jessica Donigan, MD, on Surgical Management of High-Risk Non-Melanoma Skin Cancers

View More

Advertisement

JNCCN Spotlights

(NEW) Cemiplimab Combination Treatment for Solid Organ Transplant Recipients

Cemiplimab-rwlc in Cutaneous Squamous Cell Carcinoma

(UPDATE) Cemiplimab in Cutaneous Squamous Cell Carcinoma

Cetuximab (Erbitux®) – (Non-Melanoma Skin Cancers)

Avelumab (Bavencio)

View More

More

News

Pediatric Cutaneous Melanoma: Recommendations for Diagnosis and Treatment

Immune Biomarkers as Predictors of Survival and Risk in Patients With Melanoma

Advanced Merkel Cell Carcinoma: How Effective Is Immunotherapy Rechallenge?

SITC 2024: Addition of Radiotherapy to Immunotherapy in Advanced Merkel Cell Carcinoma

SITC 2024: Predicting Recurrence With ctDNA Biomarker in High-Risk Melanoma

Is Immunotherapy Efficacious for Children and Adolescents With Melanoma?

Does Age Impact Recurrence After Image-Guided Superficial Radiotherapy for Skin Cancers?

Does Skin Screening Alter the Incidence of Skin Cancer? Australian Researchers Weigh In

View More

Advertisement

Published

Medical Literature

Early-Onset Merkel Cell Carcinoma: A New Member of the Family of Heritable Cancers?

Basal Cell Skin Cancer: Updated NCCN Guidelines Focus on Risk Stratification

Skin Cancer Prevention Measures Among Hispanic Individuals in Florida and Puerto Rico

Topical Patches for Non-Melanoma Skin Cancer: Collaboration May Conquer Challenges

View More

Ongoing

CE Activities

Updates to the Management of Cutaneous Melanoma

A Case From the Real World: Treating Advanced Melanoma as Part of the Interdisciplinary Team

Case Series: Defining the Role of Immunotherapy Across Melanoma Care

Delivering Equitable, Patient-Centered Care in Advanced Melanoma

View More

Available

Clinical Trials

Phase 2 Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinoma

Double-Blind Study of Adjuvant Cemiplimab Vs Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma

Neoadjuvant Atezolizumab in Surgically Resectable Advanced Cutaneous Squamous Cell Carcinoma

A Phase 1B/2 Study of RP1 in Solid Organ Transplant Patients With Advanced Cutaneous Malignancies

View More

Resources

For Your Patients

AIM at Skin Cancer Offers Clinician Guidance on Patient Resources and Education

Mayo Clinic - Skin Cancer

American Cancer Society - Skin Cancer Fact Sheet

Water’s Edge Dermatology

View More

Sections

360 Hub

NCCN Resources

Copyright^© 2024 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.